Related by context. All words. (Click for frequent words.) 73 allele frequencies 67 homozygotes 66 Supplementary Table 66 heterozygotes 66 rs# [004] 65 germline mutations 65 nucleotide substitutions 64 linkage disequilibrium LD 63 allelic 63 penetrance 63 Fig. 3b 63 mosaicism 63 homozygosity 62 autosomes 62 CC genotype 62 haplogroups 62 genotypic 62 orthologs 62 thyroid carcinoma 62 microdeletions 62 variant allele 62 sequence homology 62 rs# [002] 61 TIMP 61 #q#.# [002] 61 multivariable analysis 61 indels 61 heterozygous 61 PTPN# 61 histologic subtype 61 mRNA expression 61 differentially expressed genes 61 nodal metastases 61 allelic variants 61 hepatocellular carcinomas 61 pathogenic mutations 61 rs# [001] 61 ABCB1 61 fig. S1 61 PCa 61 immunoreactivity 61 epistasis 61 monozygotic twins 61 missense mutations 61 HBV genotype 61 morphologic 60 histopathologic 60 adnexal mass 60 COL#A# 60 atheroma volume 60 K#N 60 homozygote 60 aminotransferase 60 mutant allele 60 LV ejection fraction 60 karyotype 60 K ras mutations 60 hamartomas 60 NNRTI resistance 60 ventricular myocardium 60 phenotypic variation 60 K#R [002] 60 intraobserver 60 gene polymorphisms 60 substrate specificity 60 echogenicity 60 QTLs 60 MGUS 60 Figure 1C 60 TOP2A gene 60 HMGA1 60 serum PTH 60 HRCT 60 advanced adenoma 60 #OHD 60 metabolite concentrations 59 IPAH 59 indel 59 gene rearrangements 59 genetic loci 59 fig. S2 59 μmol L 59 urothelial carcinoma 59 Histopathologic 59 chromosomal rearrangement 59 seropositivity 59 karyotypes 59 TMPRSS2 ERG 59 T2 lesions 59 infarcts 59 breast carcinomas 59 isoenzyme 59 Fig. 1E 59 parasitaemia 59 ploidy 59 cTnT 59 rs# [003] 59 pg ml 59 familial clustering 59 immunostaining 59 TP# mutations 59 spontaneous mutation 59 prostate carcinoma 59 Haplotype 59 NRTI resistance 59 IL#B 59 gene polymorphism 59 GSTM1 59 definite stent thrombosis 59 microdeletion 59 CIN2 + 59 malignant nodules 59 fig. S4 59 MLH1 59 hyperplastic 59 serum aminotransferase levels 59 lung adenocarcinomas 59 #p#.# [002] 59 Multivariate analysis 59 endometrioid 59 linkage disequilibrium 58 methyltransferase 58 confidence intervals CIs 58 extracapsular extension 58 clinicopathologic 58 dizygotic twins 58 lymphocytosis 58 neurological manifestations 58 Histologic 58 serum concentrations 58 nucleotide sequence 58 Kruskal Wallis test 58 laterality 58 pulmonary nodules 58 dinucleotide 58 hydronephrosis 58 total thyroidectomy 58 Supplementary Fig 58 coding genes 58 haplogroup 58 D#N 58 functional polymorphism 58 promoter methylation 58 seronegative 58 renal pelvis 58 CD# expression [001] 58 RT PCR assay 58 intact parathyroid hormone 58 operon 58 logistic regression model 58 pT2 58 gastric adenocarcinoma 58 variant alleles 58 variant rs# 58 paternally inherited 58 ASCUS 58 scintigraphic 58 haplotypes 58 missense 58 IgA deficiency 58 SMAD4 58 regression coefficient 58 CIN3 58 HGPIN 58 frameshift mutation 58 SNP rs# [002] 58 HER2 expression 58 intergenic 58 cellularity 58 pleural fluid 58 thyrotropin 58 mIU ml 58 chromosomal aberrations 58 normal karyotype 58 bivariate 58 lymphovascular invasion 58 #S rRNA genes 58 metaplasia 58 SUVmax 58 CagA 58 constitutively active 58 X4 viruses 58 CHD7 58 paralogs 58 antibody titer 58 thyroglobulin 58 etiologic 58 MDRD 58 mRNA transcripts 58 CYP#C# [002] 58 SSc 58 Genotypic 58 univariate analysis 58 mucinous 58 genotypic resistance 58 UGT#B# 57 PCR amplified 57 Bonferroni correction 57 neoplasms 57 methylated DNA 57 SCr 57 SLNB 57 intergenic regions 57 monozygotic 57 renal tumors 57 ADPKD 57 orthologous genes 57 fig. S6 57 somatic mutations 57 interobserver reliability 57 activating mutations 57 lymph node metastasis 57 creatinine ratio 57 univariate 57 BRCA1 mutation carriers 57 HLA DRB1 57 unmethylated 57 #p# [003] 57 cytopathic 57 serovar 57 chimpanzee genomes 57 cytokeratin 57 figs. 57 supratentorial 57 neoplasm 57 RNFL thickness 57 somatic mutation 57 genotype 57 de novo mutations 57 ALT flares 57 serum ALT 57 plasmacytoid 57 VNTR 57 κ 57 multivariate logistic regression 57 interobserver agreement 57 hyperintense lesions 57 ALK gene 57 gene locus 57 Fig. 3B 57 -#.# ± [002] 57 urothelial 57 mammographic density 57 p# activation 57 neoplastic 57 histological subtype 57 FDG uptake 57 ± SEM 57 TT genotype 57 intracranial hemorrhage ICH 57 chloride secretion 57 pairwise comparisons 57 MMSE score 57 μg ml 57 confidence interval #.#-#.# 57 ANCOVA 57 TEAEs 57 CYP #D# 57 ERBB2 57 MIC# [001] 57 APOE genotype 57 coinfection 57 SSc patients 57 pilocytic astrocytomas 57 alanine aminotransferase ALT 57 hyperintensity 57 CD4 + CD8 + 57 multivariable adjusted 57 advanced neoplasia 57 pT3 57 groove binder 57 gastric carcinoma 57 missense mutation 57 histopathological 57 biochemical recurrence 57 isotypes 57 SCN5A 57 leiomyoma 57 MMP# 57 F FDG uptake 57 #S rRNA gene 57 sonographically 57 histocompatibility 57 ECG abnormalities 57 clade B 57 aneuploidies 57 cytochrome b 57 Leydig cell 57 Univariate 57 haplotype 57 PaO 2 57 baseline LDH 57 lactate dehydrogenase 57 TOP2A 57 carotid plaque 57 LRAT 57 HBsAg 57 CHEK2 57 HLA DRB1 * 57 adiponectin concentrations 57 Figure 1A 57 promoter polymorphism 57 univariate analyzes 57 nmol 57 leukocyte count 57 poor metabolizers 57 LPA gene 57 insertion deletion 57 splice variants 57 phylogenetically 57 proband 56 adenocarcinomas 56 TMPRSS2 ERG fusion 56 papillary RCC 56 coronary stenosis 56 Immunohistochemical staining 56 artery stenosis 56 lumbar spine BMD 56 S aureus 56 Supplemental Figure 56 histologic findings 56 statistical significance p 56 postoperative complication 56 C. albicans 56 cytogenetic abnormalities 56 liver transplant recipients 56 Fig. 1b 56 neoplasias 56 ANOVA 56 coexpression 56 heterozygosity 56 pathologic diagnosis 56 fractional anisotropy 56 S. enterica 56 malignant lesions 56 N. gonorrhoeae 56 MetS 56 chromosome #q# [002] 56 MSH2 56 tyrosine phosphorylation 56 polymorphisms 56 carcinoids 56 seminomas 56 serum TSH 56 amino acid substitutions 56 renal cysts 56 eosinophilia 56 peritoneal fluid 56 breast carcinoma 56 haematopoietic 56 FLT3 56 multivariate analyzes 56 δ 56 villous atrophy 56 H#K#me# 56 Fig. 2C 56 elevated LDH 56 sporadic ALS 56 coding sequences 56 radical nephrectomy 56 genetic polymorphism 56 causative mutation 56 Univariate analysis 56 LVNC 56 ribosomal protein 56 mutated K ras 56 myeloproliferative diseases 56 carotid stenosis 56 inactivating mutations 56 covariate 56 activating mutation 56 HLA B# 56 steroidogenic 56 HBV genotypes 56 axillary lymph nodes 56 M. genitalium 56 GenBank accession 56 RFLP 56 transgene expression 56 UGT#A# * 56 apolipoproteins 56 genetic heterogeneity 56 immunofluorescence staining 56 Postoperative complications 56 BRCA1 mutations 56 APOE e4 56 prostate cancer CaP 56 monophyletic 56 chromosomal alterations 56 VKORC1 56 logistic regression analyzes 56 alveolar epithelial cells 56 isoprostane 56 estrogen receptor ER 56 Fig. 2b 56 Fig. 3a 56 ORFs 56 methylenetetrahydrofolate reductase 56 phenotypically 56 hippocampal atrophy 56 astrocytic 56 alanine aminotransferase 56 fluorescence intensity 56 transgenic mice expressing 56 MYH9 gene 56 T. vaginalis 56 miRNA expression 56 alleles 56 Eq. 56 APOL1 56 enteroviral 56 JAK2 mutation 56 inhibin B 56 lymphadenopathy 56 thyrotropin levels 56 coronary artery stenosis 56 troponin T 56 Fig. 2A 56 apo B 56 cagA 56 ALT elevation 56 intestinal metaplasia 56 sexual dimorphism 56 spontaneous mutations 56 genes differentially expressed 56 anti JCV antibodies 56 NGAL 56 % Confidence Interval 56 immunohistochemical analysis 56 breast cancer subtypes 56 SCN1A 56 IgG antibody 56 alternatively spliced 56 polyposis 56 schwannomas 56 atypical hyperplasia 56 hypoperfusion 56 electrophysiologic 56 invasive carcinomas 56 TMEM#B 56 HOMA IR 56 proteomes 56 Fig. 1a 56 proteolytic cleavage 56 squamous 56 microsatellite instability 56 BRCA2 mutation carriers 56 SNP rs# [001] 56 carotid artery thickness 56 KRAS mutations 56 micrometastasis 56 methylation patterns 56 hamartoma 56 CORE OM 56 apolipoprotein E gene 56 lupus anticoagulant 56 clefting 55 #q# [001] 55 immunodominant 55 ABL1 55 CCR5 delta# 55 microvessel density 55 -#.# log# 55 dimeric 55 multiple logistic regression 55 HLA A2 55 nucleolar 55 vivax 55 homologous sequences 55 dizygotic 55 papillary 55 retinol binding protein 55 splenic 55 C#Y 55 kappa = 55 surgically resected 55 radiographic findings 55 chromosomal deletions 55 NMIBC 55 interobserver 55 C#BL/#J 55 brain parenchyma 55 DLTs 55 phylogenetic analyzes 55 histologic 55 Immunohistochemical analysis 55 bronchoalveolar lavage 55 autosomal 55 TRUS 55 #β estradiol 55 distant metastases 55 monogenic 55 introgression 55 recombination hotspots 55 lesional 55 GSTP1 55 chromosome #q#.# [001] 55 quasispecies 55 multivariate Cox 55 HCV genotype 55 HbA1C levels 55 phenotypic expression 55 CEACAM1 55 basal cell carcinoma BCC 55 ileal 55 splice junctions 55 tertile 55 mtDNA mutations 55 hepatoma 55 leiomyomas 55 hypothalamic pituitary 55 familial aggregation 55 pulmonary metastases 55 HPV subtypes 55 bile acid metabolism 55 chi squared 55 seroprevalence 55 σ 55 polycystin 55 morphological 55 HBeAg negative 55 rCBF 55 lysine residues 55 calculi 55 CHD mortality 55 T1a 55 p# mutation 55 proximal colon 55 posttranslational modifications 55 TUNEL 55 CYP#D# 55 hypermethylated 55 Fig. 2B 55 Phylogenetic analysis 55 tumoral 55 colorectal neoplasia 55 glutamate glutamine 55 genetic polymorphisms 55 intronic 55 Homozygous 55 hyperintensities 55 Cytogenetic 55 tPSA 55 F FLT 55 apolipoprotein B 55 polypoid lesions 55 atherosclerotic lesion 55 heritable variation 55 APOC3 55 M. pneumoniae 55 mutant alleles 55 alanine 55 chromosome #q 55 kidney allograft 55 β = 55 nonparametric 55 PSADT 55 differential gene expression 55 transduced 55 hematologic toxicity 55 ALT elevations 55 Dpp 55 A. thaliana 55 #q# [002] 55 liver histology 55 G allele 55 PSA nadir 55 GBA mutations 55 advanced adenomas 55 preoperative PSA 55 capsid protein 55 MYBPC3 55 NIHSS score 55 proximal tubule 55 atrophic gastritis 55 Candida species 55 synuclein 55 dopamine transporter gene 55 perfusion defect 55 aortic regurgitation 55 tumorigenicity 55 chromosomal rearrangements 55 osteochondroma 55 ^ sup #m 55 fig. S3 55 μg L 55 periventricular 55 gene APOE 55 aggrecan 55 Fig. 1c 55 cell carcinomas 55 serum albumin 55 apparent diffusion coefficient 55 leukocytosis 55 pg mL 55 Vps# 55 urine cytology 55 5q 55 cellular prion protein 55 ultrasonographic 55 virulence genes 55 Sjögren syndrome 55 MnSOD 55 lymph node involvement 55 HBeAg 55 T1 weighted images 55 inhibin 55 Genotypes 55 gadolinium enhanced 55 hypogonadal 55 luminal 55 del 5q 55 CI #.#-#.# [001] 55 polymorphism 55 HCCs 55 chronicity 55 kDa protein 55 meningiomas 55 endometrial thickness 55 mL/min/#.# m 2 55 Activating mutations 55 colorectal adenoma 55 miRNAs miR 55 FDG PET imaging 55 immunohistochemical 55 genotypes 55 IL 1ß 55 ccRCC 55 beta globin 55 FGFR2 55 aortic insufficiency 55 hyper IgE syndrome 55 sarcomatoid 55 genital tract infections 55 prolonged QT interval 55 gastric cardia 55 ascertainment bias 55 albumin excretion 55 ligand receptor 55 lactis 55 gametocytes 55 serum lipid 55 phenotypes 55 Amino acid 55 euthyroid 55 angiographically 55 HLA DR 55 polypoid 55 metastatic lymph nodes 55 IL#B gene 55 DRB1 * 55 Pearson correlation coefficient 54 Hazard Ratio HR 54 Phylogenetic analyzes 54 colonic mucosa 54 hypogonadotropic hypogonadism 54 variance ANOVA 54 mononuclear 54 femoral neck fracture 54 MEFs 54 protein tyrosine phosphatase 54 succinate dehydrogenase 54 XLHED 54 R#W [002] 54 adenoma 54 catechol O methyltransferase 54 colorectal carcinoma 54 prognostic significance 54 inherited mutations 54 pCR 54 ADRB2 54 #S rRNA 54 sonographic findings 54 Fig. 2a 54 EBNA1 54 hnRNP 54 genes CYP#C# 54 beta actin 54 CD4 + CD# 54 papillomas 54 amino acid residues 54 congenital anomalies 54 CD3 + 54 MRSA isolates 54 nitrotyrosine 54 MTHFR 54 osteochondromas 54 autosomal dominant inheritance 54 CD# CD# 54 bladder carcinoma 54 DNA methylation patterns 54 intraoperative complications 54 homodimer 54 hemoglobin Hb 54 microcephalin 54 RRM1 54 triiodothyronine 54 sCJD 54 hyperplastic polyps 54 logistic regression analysis 54 TIMP 1 54 CD#c 54 macroalbuminuria 54 regression coefficients 54 Supplementary Figs 54 serum HBV DNA 54 V#F mutation 54 herpesviruses 54 cerebellar 54 homologues 54 obstructive coronary artery 54 lymphocytic 54 amino acid sequences 54 IgG4 54 cytochrome c oxidase 54 cytologic 54 CYP#D# gene 54 quantitative trait loci 54 amino terminal 54 affective psychosis 54 femora 54 glomerular 54 Figure 2C 54 Fas ligand 54 autonomic dysfunction 54 glomerular filtration rate 54 LV dysfunction 54 Fig. 1A 54 osteoblastic 54 K ras gene 54 T2 weighted images 54 neoplastic lesions 54 HbF 54 p# mutations 54 BRCA2 mutation 54 CsA 54 C#T [002] 54 proteoglycan 54 metabolomic profiles 54 Kaplan Meier analysis 54 hepatic enzymes 54 clinicopathological features 54 pmol 54 isoforms 54 diffusion tensor 54 inherited maternally 54 serum homocysteine 54 microsatellite markers 54 EF Tu 54 colorectal polyp 54 BRAF V#E mutation 54 tumor histology 54 cytidine 54 autosomal dominant 54 colocalization 54 maternally inherited 54 MACCE 54 serum retinol 54 Polymorphisms 54 mesangial 54 LTBI 54 interleukin IL 54 dsDNA 54 QTc prolongation 54 histopathologic findings 54 immunoreactive 54 cystatin C 54 HER2 amplification 54 Trichophyton rubrum 54 λ 54 r2 = 54 CD# expression [002] 54 eosinophil count 54 PON1 54 albicans 54 polygenic 54 3'UTR 54 EGFR mutations 54 qRT PCR 54 independent prognostic marker 54 CDKN2A 54 CD# + [001] 54 ABCB1 gene 54 distal femur 54 ubiquitinated 54 chromosome #q# [001] 54 immunoblotting 54 QTcF 54 #q#.# [001] 54 p# biomarker 54 lymphadenectomy 54 wildtype 54 mesotheliomas 54 tryptase 54 beta subunit 54 congenital abnormalities 54 syngeneic 54 ertapenem 54 distant metastasis 54 radical prostatectomy RP 54 ZNF# 54 microg 54 undetectable HBV DNA 54 thyroid nodules 54 allele 54 SHANK3 54 lobular carcinomas 54 p tau 54 CFH gene 54 motor neuron degeneration 54 APOE ε4 54 genomic deletions 54 perioperative complications 54 etiologic agent 54 vesicle fusion 54 virological response 54 deoxy 54 ultrastructural 54 histologic subtypes 54 synteny 54 albumin excretion rate 54 proximal femur 54 HLA DQ2 54 myocardial fibrosis 54 lymph node metastases 54 node metastases 54 Thyroid nodules 54 NR#A# 54 pmol L 54 laboratory abnormalities 54 neuroligins 54 antitrypsin 54 M#V 54 clinico pathological 54 statistically significant p = 54 HMGA2 54 colorectal cancer incidence 54 immunohistochemical staining 54 cystatin 54 papillary renal cell carcinoma 54 neurologic deficits 54 T1D 54 trabecular 54 creatine kinase MB 54 Neisseria gonorrhoeae 54 cTnI 54 GSTT1 54 esophageal carcinoma 54 ADH1B * 54 KRAS oncogene 54 allelic variation 54 transcriptional profiles 54 colonic polyps 54 Trichomonas vaginalis 54 CAG repeats 54 microbiologically evaluable 54 fig. S8 54 NNT = 54 β1 54 Baseline characteristics 54 Phenotypic 54 hyperhomocysteinemia 54 AST ALT 54 gene amplification 54 Å -1 54 metazoan 54 ADAMTS# 54 metastatic neuroendocrine tumors 54 multivariable Cox 54 micrometastases 54 transferase 54 pulvinar 54 apoE 54 GlcNAc 54 clinically insignificant 54 incidentalomas 54 Mendelian 54 APOA5 54 probands 54 DGGE 54 capsular polysaccharide 54 myeloid 54 Heterozygous 54 clinicopathological 54 ischemic lesions 54 femoral neck BMD 54 TNFR1 54 mitochondrial DNA mtDNA 54 nondiabetic 54 ROC curves 54 urine albumin 53 serum HCV RNA 53 pheochromocytoma 53 NF1 gene 53 IGFBP 53 p# NTR 53 glucocorticoid induced 53 HepG2 cells 53 postoperative radiographs 53 punctate 53 CYP#C# * 53 Serious AEs 53 peptidase 53 vaginalis 53 DNA rearrangements 53 LPS induced 53 F FDG PET 53 aneuploid 53 differentially regulated 53 MDR1 53 PGCs 53 #p# [001] 53 PFGE 53 neuritic 53 Genotype 53 CFTR gene 53 μ opioid receptor 53 Clusterin 53 constitutively expressed 53 downregulated 53 interleukin IL -6 53 CSF biomarkers 53 fluconazole resistant 53 ß = 53 ω 53 HIV HCV coinfected 53 DR4 53 peripheral blood mononuclear 53 locoregional recurrence 53 erythrocytes 53 TSC1 53 E#/E# [001] 53 #q# deletion 53 nucleated cells 53 mean ± SEM 53 evolutionarily conserved 53 KCNH2 53 chromosome #p#.# 53 PALB2 53 rebleeding 53 inhibitory receptor 53 dysbindin 53 Alkaline Phosphatase 53 % CI #.#-#.# [003] 53 femoral neck 53 microscopic hematuria 53 baseline FEV 53 ESR1 53 VEGFR1 53 biochemical abnormalities 53 PITX2 53 Genetic variation 53 transvaginal sonography 53 SAXS 53 nonalcoholic steatohepatitis NASH 53 subcellular compartments 53 phosphorylase 53 cDNAs 53 pituitary adenomas 53 AUCs 53 peritumoral 53 intraepithelial 53 null mice 53 serum creatinine levels 53 chlamydial infection 53 gene loci 53 P = .# 53 clades 53 Descriptive statistics 53 bivariate analyzes 53 mIU L 53 MLL2 53 extrahepatic 53 MTHFR gene 53 TCF#L# gene 53 FMR1 53 PBMCs 53 z = 53 γ 53 Fig. 3C 53 μg liter 53 hypointense 53 lymphopenia 53 genomewide 53 Fig. 4a 53 EAAT2 53 periprocedural MI 53 ug ml 53 locoregional 53 interindividual variability 53 subtype 53 P ≤ 53 HER2 overexpression 53 epithelia 53 S. maltophilia 53 TCF4 53 immunocompetent 53 Polymorphism 53 SRY gene